62
Discover us

05 December 2024

opnMe has won the 2024 Best Practice Award at the 11th Annual World Open Innovation Conference (WOIC) at the University of California in Berkeley. Explore the full article and learn more about WOIC and how opnMe stood out.

42
Discover us

4 December 2024

In a recent interview with Heping Xu and Mei Chen, Professors at the Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast, we had the opportunity to gain valuable insights into their collaboration with Boehringer Ingelheim and how opnMe has advanced their research in retinal disease.

68
Discover us

25 November 2024

Watch the recorded session of our opnMe online seminar from November 14, 2024, to discover how the selective Cathepsin C (CatC) inhibitor, BI-9740, from opnMe has helped elucidate new roles of CatC signaling in immune response and cardiovascular disease.

63
Molecules for free

18 November 2024

Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein that is activated when it binds to ligands from the EGF family. This induces receptor dimerization, tyrosine autophosphorylation, and leads to cell proliferation. It is widely expressed across multiple human tissues, including skin, brain, colon, liver,...

51
Discover us

5 November 2024

We recently had the chance to speak to Laura-Marie Zimmermann, a former postdoctoral researcher at the University Hospital Cologne, about her experience with opnMe and her interaction with scientists from Boehringer Ingelheim.

Discover us

Hear from our collaborators

slide 1 to 2 of 13